Re: Farmas USA
BCRX
-60% en premarket
BioCryst Rocked by Failed OPuS-2 Study
https://www.briefing.com/investor/analysis/story-stocks/biocryst-rocked-by-failed-opus2-study.htm
y los Baker Brothers tenian un 20% de la compañia
edito: sorry, Pathwin, no lei tu post